Ready or Risky: How to Tell If Your Healthcare Business Can Survive Buyer Scrutiny
Ready or Risky: How to Tell If Your Healthcare Business Can Survive Buyer Scrutiny Key Takeaways Why Buyer Scrutiny Is Tougher Now Healthcare deal activity has improved, but scrutiny has become sharper. Buyers are paying close attention to financial discipline, compliance exposure, and execution certainty before moving forward. That is why many owners work with […]
Read More
Healthcare CEO Guide: Avoiding Buyer “Ghosting” After Verbal Commitments
Healthcare CEO Guide: Avoiding Buyer “Ghosting” After Verbal Commitments Key Takeaways Why Healthcare Buyers Go Silent After Verbal Agreements Healthcare CEOs often face a confusing scenario: strong enthusiasm, verbal agreement on valuation, alignment on structure — and then silence. In healthcare M&A, verbal alignment is only step one. Buyers must still secure internal investment committee […]
Read More
Cybersecurity and PHI Exposure: The New Board-Level M&A Risk in Healthcare
Cybersecurity and PHI Exposure: The New Board-Level M&A Risk in Healthcare Key Takeaways Introduction Healthcare mergers and acquisitions are no longer judged solely on revenue, patient volume, or EBITDA multiples. In today’s environment, cybersecurity posture and PHI exposure have become decisive factors in whether a deal closes, how it is priced, and who ultimately bears […]
Read More